Key result
NAFLD linked to ~15% higher CIMT vs chronic viral hepatitis.
Why the study?
Does NAFLD increase the risk of atherosclerosis and cardiovascular disease compared to chronic viral hepatitis?
Population
40 patients total: 20 with non-alcoholic fatty liver disease and 20 age- and gender-matched controls with…
Comparison
Non-alcoholic fatty liver disease (NAFLD) vs Chronic viral hepatitis
Design
Cross-sectional
Authors
Loading...
NAFLD was associated with higher cIMT than viral hepatitis; leaves open metabolic syndrome mediation pending prospective cohorts.
Case-Control (n=40)
Does NAFLD increase the risk of atherosclerosis and cardiovascular disease compared to chronic viral hepatitis?
Absolute Event Rate: 0.7% vs 0.61%
p-value: p=0.007
NAFLD is associated with increased subclinical atherosclerosis and higher estimated 10-year cardiovascular risk compared to chronic viral hepatitis, an effect dependent on the presence of metabolic syndrome.
Guleria et al. (2013) conducted a case-control in Non-alcoholic fatty liver disease (NAFLD) (n=40). Non-alcoholic fatty liver disease (NAFLD) vs. Chronic viral hepatitis was evaluated on Carotid intima-media thickness (CIMT) (p=0.007). Non-alcoholic fatty liver disease was associated with significantly higher mean carotid intima-media thickness compared to chronic viral hepatitis controls (0.70 vs. 0.61 mm; p=0.007).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: